Great Novel Therapeutics Biotech & Medicals Intangible Assets

As of the most recent data (June 2026), 7427.TWO shows a intangible assets of $26M. That compares with $26M in the prior-year period — down 0.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 7427.TWO's intangible assets is now $26M (was $26M) — a 0.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Great Novel Therapeutics Biotech & Medicals is outperforming or lagging.

Tracking 7427.TWO's intangible assets over time shows whether Great Novel Therapeutics Biotech & Medicals is scaling, shrinking, or reshaping that part of the business. The current reading is $26M That compares with $26M in the prior-year period — down 0.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Great Novel Therapeutics Biotech & Medicals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $26M) with ownership activity and broader fundamentals.

Great Novel Therapeutics Biotech & Medicals's intangible assets is $26M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.